Endoscopic evaluation of celiac disease severity and its correlation with histopathological aspects of the duodenal mucosa

Background and study aims: Celiac disease (CD) is a chronic systemic autoimmune disorder affecting genetically predisposed individuals, triggered and maintained by the ingestion of gluten. Triggered and maintained by the ingestion of gluten, celiac disease is a chronic systemic autoimmune disorder affecting genetically predisposed individuals. Persistent related inflammation of the duodenal mucosa causes atrophy architecture detectable on esophagogastroduodenoscopy (EGD) and histopathology. We investigated the association between endoscopic features and histopathological findings (Marsh) for duodenal mucosa in celiac disease patients and propose an endoscopic classification of severity.

Patients and methods: Between January 2000 and March 2010, an electronic database containing 34,540 EDGs of patients aged > 14 years was searched for cases of CD. Out of 109 cases, 85 met the inclusion criteria: conventional EGD combined with chromoendoscopy, zoom and biopsy. EGD types 0, I and II corresponds to Marsh grades 0, 1 and 2, respectively, while EGD type III corresponds to Marsh grade 3 and 4.

Results: Five patients (5.8 %) were EGD I but not Marsh grade 1; 25 patients (29.4 %) were EGD II, 4 of whom (16 %) were classified as Marsh grade 2; and 55 patients (64.7 %) were EGD III, 51 (92.7 %) of whom were classified as Marsh grades 3 and 4. The Spearman correlation coefficient (r = 0.33) revealed a significant association between the methods (P = 0.002).

Conclusions: Changes in the duodenal mucosa detected on EGD were significantly and positively associated with histopathologic findings. The use of chromoendoscopy in addition to conventional EGD enhances changes in the duodenal mucosa and permits diagnosis of CD, even in routine examinations. The proposed endoscopic classification is practical and easily reproducible and provides valuable information regarding disease extension.

• References

• 1 Dowd B, Walker-Smith J. Samuel Gee, Aretaeus, and the coeliac affection. BMJ 1974; 2: 45-47
• 2 Kotze LMS, Utiyama SRR, Kotze LR. Doença celíaca. In: Coelho J. Aparelho digestivo. Clínica e Cirurgia. 4. ed. São Paulo: Atheneu; 2012: 855-876
• 3 Dickey W. Endoscopic markers for celiac disease. Nat Rev Gastroenterol Hepatol 2006; 3: 546-551
• 4 Ianiro G, Gasbarrini A, Cammarota G. Endoscopic tools for the diagnosis and evaluation of celiac disease. World J Gastroenterol 2013; 19: 8562-8570
• 5 Green PHR. The many faces of celiac disease: clinic presentation of celiac disease in the adult population. Gastroenterol 2005; 128: 574-578
• 6 Brocchi E, Corazza GR, Caletti G et al. Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med 1988; 319: 741-744
• 7 Ianiro G, Gasbarrini A, Cammarota G. Endoscopic tools for the diagnosis and evaluation of celiac disease. World J Gastroenterol 2013; 19: 8562-8570
• 8 Jabbari M, Wild G, Goresky CA et al. Scalloped valvulae conniventes: an endoscopic marker of celiac sprue. Gastroenterol 1989; 95: 1518-1522
• 9 Cammarota G, Fedeli P, Gasbarrini A. Emerging technologies in upper gastrointestinal endoscopy and celiac disease. Nat Rev Gastroenterol Hepatol 2009; 6: 47-56
• 10 Gasbarrini A, Ojetti V, Cuoco L et al. Lack of endoscopic visualization of intestinal villi with the “immersion technique” in overt atrophic celiac disease. Gastrointest Endosc 2003; 57: 348-351
• 11 Holdstock G, Eade OE, Isaacson P et al. Endoscopic duodenal biopsies in coeliac disease and duodenitis. Scand J Gastroenterol Suppl 1979; 14: 717-720
• 12 Badreldin R, Barrett P, Wooff DA et al. How good is zoom endoscopy for assessment of villous atrophy in coeliac disease?. Endoscopy 2005; 37: 994-998
• 13 Bardella MT, Minoli G, Ravizza D et al. Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med 2000; 160: 1489-1491
• 14 Fasano A. Novel therapeutic/lntegrative approaches for celiac disease and dermatitis herpetiformis. Clin Dev Immunol 2012;
• 15 WGO. World Gastroenterology Organization. Practice guidelines: doença celíaca. 2005 Disponível em: http://www.worldgastroenterology.org/assetsdownloads/ptlpdf/guidelines/celiac_disease_pt.pdf Acesso em: 10 jul. 2013.
• 16 Volta U, Molinaro N, de Franceschi L et al. IgA antiendomysial antibodies on human umbilical cord tissue for celiac disease screening. Dig Dis Sci 1995; 40: 1902-1905
• 17 Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801
• 18 Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterol 1992; 102: 330-354
• 19 Green PHR, Stavropoulos SN, Panagi SG et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126-131
• 20 Lebwohl B, Bhagat G, Markoff S et al. Are there legal implications for missed opportunities for the diagnosis of celiac disease. Dig Dis Sci 2013; 58: 1293-1298
• 21 Magazzu G, Bottani M, Tuccari G et al. Upper gastrointestinal endoscopy can be a reliable screening tool for celiac sprue in adults. J Clin Gastroenterol 1994; 19: 255-258
• 22 Ozaslan E, Akkorlu S, Eskioğlu E et al. Prevalence of silent celiac disease in patients with dyspepsia. Dig Dis Sci 2007; 52: 692-697
• 23 Fasano A, Berti I, Gerarduzzi T et al. Prevalence of celiac disease in at-risk and not at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-292
• 24 Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterol 1999; 117: 297-303
• 25 Hankey GL, Holmes GK. Celiac disease in the elderly. Gut 1994; 35: 65-67
• 26 Oliveira RP, Sdepanian VL, Barreto JA et al. High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody. Eur J Gastroenterol Hepatol 2007; 19: 43-49
• 27 Pereira MAG, Ortiz-Agostinho CL, Nishitokukado I et al. Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry. World J Gastroenterol 2006; 12: 6546
• 28 Nisihara RM, Kotze LM, Utiyama SR et al. Celiac disease in children and adolescents with Down syndrome. J Pediatr (Rio J) 2005; 81: 373-376
• 29 Shamaly H, Hartman C, Pollack S et al. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. J Pediatr Gastroenterol Nutr 2007; 44: 583-586
• 30 Bettendorf M, Doerr HG, Hauffa BP et al. Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J Pediatr Endocrinol Metab 2006; 19: 149-154
• 31 Baptista ML, Koda YK, Mitsunori R et al. Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2005; 41: 621-624
• 32 Goh C, Banerjee K. Prevalence of coeliac disease in children and adolescents with type 1 diabetes mellitus in a clinic based population. Postgrad Med J 2007; 83: 132-136
• 33 Lo A, Guelrud M, Essenfeld H et al. Classification of villous atrophy with enhaced magnification endoscopy in patients with celiac disease and tropical sprue. Gastrointest Endosc 2007; 66
• 34 Banerjee R, Shekharan A, Ramji C et al. Role of magnification endoscopy in the diagnosis and evaluation of suspected celiac disease: correlation with histology. Indian J Gastroenterol 2007; v. 26